Conatus Pharmaceuticals Inc (CNAT.OQ)

CNAT.OQ on NASDAQ Stock Exchange Global Market

8.55USD
26 Nov 2014
Price Change (% chg)

$0.54 (+6.74%)
Prev Close
$8.01
Open
$8.12
Day's High
$8.60
Day's Low
$7.85
Volume
105,980
Avg. Vol
44,972
52-wk High
$15.65
52-wk Low
$5.06

CNAT.OQ

Chart for CNAT.OQ

About

Conatus Pharmaceuticals Inc. is a biotechnology company focused on the development and commercialization of medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. The... (more)

Overall

Beta: --
Market Cap (Mil.): $134.14
Shares Outstanding (Mil.): 15.69
Dividend: --
Yield (%): --

Financials

  CNAT.OQ Industry Sector
P/E (TTM): -- 219.87 38.74
EPS (TTM): -1.40 -- --
ROI: -45.17 -2.35 17.27
ROE: -45.03 -3.55 18.18
Search Stocks

Competitors

  Price Change
BASF SE (BASFn.DE) €74.68 -1.24
Johnson & Johnson (JNJ.N) $107.21 +0.51
Novartis AG (NOVN.VX) CHF92.10 +0.55
Merck & Co., Inc. (MRK.N) $59.75 +0.41
Roche Holding Ltd. (ROG.VX) CHF287.90 +0.80

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks